Skip to main content
padlock icon - secure page this page is secure

Open Access Transition Metal Catalysis for Pharmaceutical Intermediates and APIs

Download Article:
 Download
(PDF 953.6 kb)
 
Rohner AG, a medium-sized Swiss company, has moved from toll manufacturing of building blocks and starting materials to the custom manufacturing of intermediates and APIs for the life science industry. Therefore, Rohner AG has expanded its technology portfolio to new technologies such as transition metal catalysis. Examples for asymmetric hydrogenation, Suzuki coupling and carbonylation are provided. In addition, the necessary changes in equipment and project management are presented and discussed.
No References for this article.
No Supplementary Data.
No Article Media
No Metrics

Keywords: ASYMMETRIC HYDROGENATION; CARBONYLATION; CUSTOM SYNTHESIS; SUZUKI COUPLING

Document Type: Research Article

Publication date: January 1, 2005

More about this publication?
  • International Journal for Chemistry and Official Membership Journal of the Swiss Chemical Society (SCS) and its Divisions

    CHIMIA, a scientific journal for chemistry in the broadest sense, is published 10 times a year and covers the interests of a wide and diverse readership. Contributions from all fields of chemistry and related areas are considered for publication in the form of Review Articles and Notes. A characteristic feature of CHIMIA are the thematic issues, each devoted to an area of great current significance.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Information for Advertisers
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more